Publication | Open Access

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Cancer EpidemiologyPooled Exploratory AnalysisMedicineCancer ManagementImmunologyImmune Checkpoint InhibitorGlobal CohortCancer TreatmentOncologyImmune-related Adverse EventsLung Cancer